TW241268B - - Google Patents

Info

Publication number
TW241268B
TW241268B TW082107913A TW82107913A TW241268B TW 241268 B TW241268 B TW 241268B TW 082107913 A TW082107913 A TW 082107913A TW 82107913 A TW82107913 A TW 82107913A TW 241268 B TW241268 B TW 241268B
Authority
TW
Taiwan
Application number
TW082107913A
Original Assignee
Hayashibara Biochem Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hayashibara Biochem Lab filed Critical Hayashibara Biochem Lab
Application granted granted Critical
Publication of TW241268B publication Critical patent/TW241268B/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0693—Tumour cells; Cancer cells
    • C12N5/0694—Cells of blood, e.g. leukemia cells, myeloma cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/70—Undefined extracts
    • C12N2500/72—Undefined extracts from bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/05—Adjuvants
    • C12N2501/052—Lipopolysaccharides [LPS]
TW082107913A 1992-09-28 1993-09-25 TW241268B (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP28113692A JP3439490B2 (ja) 1992-09-28 1992-09-28 蛋白質とその蛋白質をコードするｄｎａ並びにその蛋白質の製造方法

Publications (1)

Publication Number Publication Date
TW241268B true TW241268B (zh) 1995-02-21

Family

ID=17634871

Family Applications (1)

Application Number Title Priority Date Filing Date
TW082107913A TW241268B (zh) 1992-09-28 1993-09-25

Country Status (6)

Country Link
US (3) US5498697A (zh)
EP (1) EP0594311B1 (zh)
JP (1) JP3439490B2 (zh)
KR (1) KR100294977B1 (zh)
DE (1) DE69331368T2 (zh)
TW (1) TW241268B (zh)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0981369B1 (en) * 1997-05-12 2004-11-17 Aphton Corporation Immunogenic compositions to the cck-b/gastrin-receptor and methods for the treatment of tumors
US20040001842A1 (en) * 1997-05-12 2004-01-01 Dov Michaeli Immunogenic compositions to the CCK-B/gastrin receptor and methods for the treatment of tumors
US6387661B1 (en) * 2001-03-23 2002-05-14 Pe Corporation (Ny) Nucleic acid molecules encoding human aminoacylase proteins
WO2002076499A2 (en) 2001-03-23 2002-10-03 Aphton Corporation Combination treatment of pancreatic cancer
US20090191232A1 (en) 2001-05-04 2009-07-30 Gevas Philip C Combination therapy for the treatment of tumors
KR20040049830A (ko) * 2001-07-09 2004-06-12 애프톤 코포레이션 간, 폐 및 식도의 암 및 전암 상태의 치료 및 예방
CN1781023A (zh) * 2003-03-28 2006-05-31 埃弗顿有限公司 胃泌素激素免疫测定
WO2006032980A1 (en) 2004-09-22 2006-03-30 Receptor Biologix, Inc. Monoclonal antibolies to progastrin
US11583576B2 (en) 2017-06-15 2023-02-21 Cancer Advances Inc. Compositions and methods for inducing humoral and cellular immunities against tumors and cancer
CN111704658B (zh) * 2018-06-11 2021-11-16 北京市农林科学院 具有消脂护肝功能的毛木耳糖肽及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5925332A (ja) * 1982-08-04 1984-02-09 Mochida Pharmaceut Co Ltd 抗腫瘍性糖蛋白質の製法
JPS60112718A (ja) * 1983-11-21 1985-06-19 Kyorin Pharmaceut Co Ltd 抗腫瘍作用を示す蛋白性物質及びその製造方法
JP2926409B2 (ja) * 1989-05-22 1999-07-28 株式会社林原生物化学研究所 癌転移抑制因子の製造方法

Also Published As

Publication number Publication date
US5498697A (en) 1996-03-12
US5585474A (en) 1996-12-17
EP0594311B1 (en) 2001-12-19
KR940007056A (ko) 1994-04-26
DE69331368D1 (de) 2002-01-31
JPH06107693A (ja) 1994-04-19
US5827691A (en) 1998-10-27
KR100294977B1 (ko) 2001-09-17
EP0594311A1 (en) 1994-04-27
DE69331368T2 (de) 2002-08-08
JP3439490B2 (ja) 2003-08-25

Similar Documents

Publication Publication Date Title
EP0551242A3 (zh)
TW241268B (zh)
DE9302593U1 (zh)
EP0559438A3 (zh)
DE9200057U1 (zh)
TW255907B (zh)
DE9200066U1 (zh)
DE9200064U1 (zh)
DE9200192U1 (zh)
DE9200205U1 (zh)
DE9200088U1 (zh)
DE9200080U1 (zh)
DE9215859U1 (zh)
DE9200097U1 (zh)
DE9200215U1 (zh)
TW242207B (zh)
DE9200160U1 (zh)
DE9200173U1 (zh)
DE9200237U1 (zh)
DE9200212U1 (zh)
DE9200123U1 (zh)
DE9200180U1 (zh)
DE9200242U1 (zh)
DE9200204U1 (zh)
DE9200182U1 (zh)

Legal Events

Date Code Title Description
MC4A Revocation of granted patent